Call for Abstract

3rd International Conference on Clinical Microbiology & Microbial Genomics, will be organized around the theme “Advanced Approaches in Innovation & Future Directions of Clinical Microbiology”

Clinical Microbiology-2014 is comprised of 12 tracks and 84 sessions designed to offer comprehensive sessions that address current issues in Clinical Microbiology-2014.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Broad spectrum antibiotics and current development
  • Track 1-2Liver infections: Diagnosis of hepatitis and control
  • Track 1-3Gastrointestinal and urinary tract infections
  • Track 1-4Septic arthritis and osteomyelitis
  • Track 1-5Sexually transmitted infections
  • Track 1-6Clinical parasitology
  • Track 1-7Fungal infections and Anti-fungal therapeutics
  • Track 1-8Antiviral drugs and viral resistance
  • Track 1-9Microbial food poisoning and therapeutics
  • Track 2-1Advancements in pharmaceutical microbiology
  • Track 2-2Applied and environmental microbiology
  • Track 2-3Microbial metabolism and genetics
  • Track 2-4Food microbiology and safety
  • Track 2-5Hematological malignancies
  • Track 2-6Nanopatches and nanovaccination
  • Track 3-1Bacteriocins and their significance
  • Track 3-2Microbial resistance and surveillance to disinfectants
  • Track 3-3Clinical disinfectants
  • Track 3-4Anti-microbial coatings
  • Track 3-5Plasmids and bacterial resistance to biocids
  • Track 3-6Quaternary ammonium compounds against bacteria
  • Track 3-7Natural vs. synthetic antimicrobials
  • Track 4-1Host pathogen interactions
  • Track 4-2Immune mechanism in microbial infections
  • Track 4-3Immunity: Response, evasion, and tolerance
  • Track 4-4Immune mechanisms in pediatrics and geriatrics
  • Track 4-5Tuberculosis and its control
  • Track 4-6Travel medicine, tropical and parasitic diseases
  • Track 5-1Infection in the immune compromised host and transplant recepients
  • Track 5-2Community-acquired infections including CAP, sepsis
  • Track 5-3Pediatric infections
  • Track 5-4Lyme borreliosis, and toxoplasmosis
  • Track 5-5Contributions of imaging techniques in hydatidosis
  • Track 5-6Bacterial and fungal skin infections
  • Track 5-7Diabetic foot infections
  • Track 5-8Case studies in clinical microbiology
  • Track 6-1Recent trends in detection of microbial toxins
  • Track 6-2Clinical epidemiology and case studies
  • Track 6-3Biomarker tools in microbial diagnosis
  • Track 6-4Nanotechnology in microbial and viral detection
  • Track 6-5Methods for antibacterial susceptibility testing
  • Track 6-6Bacterial biochemical physiology
  • Track 6-7Pathogenesis and modern control methodologies
  • Track 7-1Zoonoses and control
  • Track 7-2Madcow disease
  • Track 7-3Mycobacteriosis
  • Track 7-4Monkey pox virus
  • Track 7-5Sheep, goatpox and swineflu viruses
  • Track 7-6Veterinary pathology
  • Track 8-1Vector-borne zoonoses: Chagas diseases and malaria
  • Track 8-2Infections arboviruses: Yellow fever & dengue
  • Track 8-3Public health and community-acquired infections
  • Track 8-4Emerging infectious diseases
  • Track 8-5Disaster management & preventive medicine
  • Track 8-6Tropical infections: Dracunculiasis
  • Track 9-1Antiretroviral therapy and current research on HIV/AIDS
  • Track 9-2Rabies and genome research
  • Track 9-3Eradication of polio: Vaccination
  • Track 9-4Clinical importance of probiotics
  • Track 10-1Bioinformatics: Sequence and genome analysis
  • Track 10-2Microbial functional genomics
  • Track 10-3Microarray expression analysis
  • Track 10-4Single cell genomics and proteomics
  • Track 10-5Metagenomics
  • Track 10-6Comparitive genomics
  • Track 10-7Microbial evolution and phylogenetics
  • Track 10-8Microbial genetics
  • Track 10-9Genome evolution and environmental genomics
  • Track 11-1Vaccines against parasite infections
  • Track 11-2Antiviral and antibacterial vaccines
  • Track 11-3Biodefense vaccines: The filovirus experience
  • Track 11-4Plant and animal based vaccines
  • Track 11-5Rotavirus vaccines
  • Track 11-6Pneumococcal vaccines
  • Track 11-7Emerging and re-emerging infectious disease vaccines
  • Track 11-8Food safety vaccines, Glyco-conjugate vaccines
  • Track 11-9Challenges in pediatric vaccination
  • Track 12-1Industrial microbiology
  • Track 12-2Applications of Biotechnology for Bio-Based Products
  • Track 12-3Microbial engineering for production of chemicals & pharmaceuticals
  • Track 12-4Industrial biochemical engineering
  • Track 12-5New approaches to enzyme and microbial technology
  • Track 12-6Bacterial bioremediation
  • Track 12-7Biotechnology and liquid biofuel production